Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy [Phase 1, Phase 2]

View source ↗

Summary

Update on a dissolving-film peanut immunotherapy for peanut allergy evaluated in Phase 1/2 trials; the study has been terminated and results were posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peanut Immunotherapy Dissolving Film (peanut immunotherapy dissolving film)

Snippet

Sponsor: Johns Hopkins University | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-07-03